Shilpa Medicare Limited
NSE SHILPAMED.NS
Shilpa Medicare Limited Net Cash Used Provided By Financing Activities for the year ending March 31, 2024: USD 16.68 M
-
Shilpa Medicare Limited Net Cash Used Provided By Financing Activities for the year ending March 31, 2023 was USD 5.57 M, a -48.94% change year over year.
-
Shilpa Medicare Limited Net Cash Used Provided By Financing Activities for the year ending March 31, 2022 was USD 10.91 M, a -81.69% change year over year.
-
Shilpa Medicare Limited Net Cash Used Provided By Financing Activities for the year ending March 31, 2021 was USD 59.60 M, a 155.89% change year over year.
-
Shilpa Medicare Limited Net Cash Used Provided By Financing Activities for the year ending March 31, 2020 was USD 23.29 M, a 1,508.84% change year over year.
| Date | Net Cash Used Provided By Financing Activities | Dividends Paid | Capital Expenditure | Effect Of Forex Changes On Cash |
|---|
Don’t Miss A Beat
| CEO | Mr. Vishnukanth Chaturbhuj Bhutada B. Pharm |
| IPO Date | Dec. 3, 2009 |
| Location | India |
| Headquarters | Shilpa House |
| Employees | 1,007 |
| Sector | Health Care |
| Industries | |
Shilpa Medicare Limited, together with its subsidiaries, engages in the manufacturing and selling active pharmaceutical ingredients (API's), intermediates, and formulations in India, the United States, Europe, and internationally. It offers oncology and non-oncology API's.; and new drug delivery systems, peptides/biotech products, specialty chemicals, etc. The company also provides contract manufacturing of various dosage forms, such as tablets, capsules, liquid injections, lyophilized injectables, and sterile dry powder injectables. It is also involved in the wind power generation activities. Shilpa Medicare Limited was incorporated in 1987 and is headquartered in Raichur, India.
Past 5 years
StockViz Staff
February 1, 2025
Any question? Send us an email